The Signal
NVDA just guided to +70% FY2028 revenue growth vs. +44% Street consensus—a signal that the TAM expansion thesis has institutional conviction even as bond yields and macro uncertainty persist. Simultaneous $13B Hugging Face acquisition chatter (via @stocktalkweekly) suggests NVDA is moving up the stack defensively: if foundational model economics compress, owning distribution and data assets buys optionality. The move says: we're not slowing, we're consolidating. This anchors risk-on appetite despite Warsh Jackson Hole speech (Friday) and Bessent's Sept 9 intervention looming—two events that could crater speculation. Until yields crack or leverage unwinds, AI supply-chain moats hold.
IMPORTANT
NVDA's forward guidance explosion + M&A pivot = institutions pricing AI as structural, not cyclical—even if rates stay sticky.
What's Moving
- $NVDA — +70% FY28 guidance vs. 44% consensus + Hugging Face $13B bid signals upstack consolidation. If executed, controls distribution and dataset risk. Street raises PT across the board (GS $300, Bernstein $400, JPM $320, Melius $420). Near-term chop mask longer thesis. (via @stocktalkweekly, @optionsmike)
- $LPTH — Defense optics lock hardens into federal enforcement. Two-week White House drone event window (per Under Secretary of Defense, 8/20) + CEO confirms Office of Strategic Capital conversations ongoing. Jan 1 germanium cliff + $111M backlog vs. $37.4M YoY = procurement lock-in catalyst. Russell inclusion + BlackRock 6.5% float = structural bid floor. (via @optimusdelta, @bussinbiotech)
- $IOVA — National sovereign fund blocked by sub-$4B biotech on FDA-approved metastatic cancer cure. Amtagvi revenue inflection binding on manufacturing. October NSCLC TIL data + endometrial trials = M&A trigger inside 12 months certain. Wells Fargo $14 PT (>2x current). (via @crypto_condom)
- Ethereum-native supply squeeze — Exit queue <60 days; ethereum:native on exchanges at 2016 lows. Tom Lee's $BMNR fund targeting 10% of ETH supply. 0.5% of TradFi US investors hold ETH via ETFs—structural bid ahead of potential Ethereum-native reserve thesis. (via @krugman87)
- $CRON (Cronos) — $825M net cash, EBITDA positive, 5.8% annualized buybacks, zero debt. Cannabis deregulation tailwinds priced in but IV dirt cheap. Positioned for THC research/medicinal regulatory inflection before term end. (via @crypto_condom)
Crosscurrents
- Macro fragility vs. AI conviction — Yields sticky; Warsh/Bessent event risk real. If yields spike or Fed signals hawkishness, speculative unwind could hit NVDA guidance euphoria fast. Bond vigilantes still in control. (via @stocktalkweekly)
- Uranium spot premium unsustainable — $DNN and $AGE accumulation thesis solid (2.3B pound deficit through 2045, negative processing fees), but spot uranium basis volatility could whipsaw near-term trades into 2027 cliff.
Tradecraft
BULL
NVDA's 70% forward guide + Hugging Face bid = conviction in AI as structural. If Warsh brings yields down Friday, risk-on unwind reverses. LPTH procurement lock into Oct-Nov = asymmetric entry window.
WATCH
Warsh Jackson Hole speech (Friday). Bessent Sept 9 intervention. LPTH White House drone event catalyst (next 2 weeks). NVDA earnings churn (already printed; guidance is the trade).
Desk Notes
- @optionsdelta — LPTH supply chain positioning accelerating; defense tech thesis unfolding exactly as predicted. Full-stack conviction.
- @crypto_condom — IOVA sovereign wealth fund block validates scarcity premium. M&A inside 12 months near-certain; derisk after 440% call gains.
- @krugman87 — Ethereum-native supply crisis structural. Exit queue and TradFi ETH adoption point to multi-year bid ahead of potential national reserve thesis.
- @stocktalkweekly — NVDA guides through macro doubt; bond vigilantes remain ultimate arbiter. Warsh speech is the clearing event for next leg.